Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
BIRMINGHAM, Ala., Dec. 15, 2025 (GLOBE NEWSWIRE) -- ServisFirst Bank, a subsidiary of ServisFirst Bancshares (NYSE:SFBS), is pleased to announce a series of significant leadership appointments as...
Read More -
HOUSTON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- ServisFirst Bank, a subsidiary of ServisFirst Bancshares (NYSE:SFBS), is pleased to announce its expansion into Texas with the opening of a new office in...
Read More
-
NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Fermi Inc. (“Fermi” or the “Company”) (NASDAQ: FRMI). The investigation...
-
RADNOR, Pa., Dec. 15, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against...
-
KINGSTOWN, St. Vincent and Grenadines, Dec. 15, 2025 (GLOBE NEWSWIRE) -- GeeFi announced an extraordinary fundraising achievement, securing over $800,000 in its ongoing presale in less than two...
-
Royal York Property Management marks two years of Canadian bank-accredited Bill Pay with 100,000+ transactions and zero fraud.
-
Vancouver, BC, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Fobi AI Inc. (TSXV:FOBI, Pink:FOBIF) (“Fobi” or the “Company”) is pleased to announce the launch of FIXYR, the Company’s new Agentic AI Customer...
-
PITTSBURGH, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Event Rental Systems (“ERS”),1 recently announced a cybersecurity incident, which impacted the personal information of an unknown number of individuals....
-
BURLINGTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company focused on pioneering pattern-breaking...
-
Fiscal Q2 2026 (which began on Aug 1, 2025 and ended Oct 31, 2025) included a $500M private placement, fueling BNC’s digital assets treasury transformation.World’s Largest BNB Treasury with over...
-
Arbitration Ruling Reaffirms Allogene’s Full Control of Cemacabtagene Ansegedleucel (Cema-Cel)Decision Reconfirms Allogene’s Expanded Sub-License Covering EU and UK Rights with Options for Japan and...
-
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST